Skip to content

Teva Pharmaceuticals USA

Recent events

Recent events tied to this brand in public sources.

Back to profile3 entries

  1. 2020

    Astellas files patent-infringement complaint against pharmaceutical companies

    Astellas Pharma Inc. and affiliated plaintiffs filed a complaint in Delaware against 21 pharmaceutical companies, alleging that their proposed generic versions of Myrbetriq would infringe the ’780 patent. The plaintiffs sought court relief; the allegations are claims in the complaint.

  2. 2020

    U.S. government sues Teva over alleged Copaxone kickbacks

    The U.S. Department of Justice sued Teva under the Federal False Claims Act. The lawsuit alleges that Teva companies used purportedly independent foundations to pay Medicare co-pays for Copaxone patients in violation of the Anti-Kickback Statute; the allegations are not presented as a court finding.

  3. 2019

    Virginia files opioid lawsuit against Teva Pharmaceuticals USA

    Virginia Attorney General Mark Herring filed a lawsuit against Teva Pharmaceuticals USA and a company it had acquired, alleging that they misrepresented the benefits and risks of products including fentanyl.